← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

SS Innovations International, Inc. (SSII) 10-Year Financial Performance & Capital Metrics

SSII • • Industrial / General
HealthcareMedical DevicesSurgical & Minimally Invasive DevicesSurgical Energy & Ablation Systems
AboutSS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.Show more
  • Revenue $21M +251.2%
  • EBITDA -$19M +9.6%
  • Net Income -$19M +8.6%
  • EPS (Diluted) -0.10 +37.5%
  • Gross Margin 40.93% +237.3%
  • EBITDA Margin -89.78% +74.3%
  • Operating Margin -91.9% +73.9%
  • Net Margin -92.74% +74.0%
  • ROE -138% +61.7%
  • ROIC -60.98% +59.0%
  • Debt/Equity 1.35 +135.3%
  • Interest Coverage -19.50 +50.6%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 15 (bottom 15%)
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Shares diluted 41.6% in last year
  • ✗Trading more than 30% below 52-week high
  • ✗Expensive at 74.7x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y-
3Y-
TTM97.65%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM31.83%

EPS CAGR

10Y-
5Y-
3Y-
TTM38.18%

ROCE

10Y Avg-505.52%
5Y Avg-381.93%
3Y Avg-177.37%
Latest-101.85%

Peer Comparison

Surgical Energy & Ablation Systems
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
BDMDBaird Medical Investment Holdings Limited47.38M1.292.6317.74%33.62%33%0.53
IVFINVO Fertility, Inc.12.26M0.81-0.03116.25%-417.01%-495.09%0.78
AEMDAethlon Medical, Inc.2.55M2.62-0.03-0.2%0.13
HYPDHyperion DeFi, Inc.29.01M3.55-0.0614.14%-73.86%-36.05%
NAOVNanoVibronix, Inc.1.85M1.70-0.1212.05%-133.04%-8.41%0.19
ALURAllurion Technologies Inc.21.55M1.76-0.15-39.94%-251.56%
RBOTVicarious Surgical Inc.18.23M2.82-0.26-380.42%0.30
TELATELA Bio, Inc.44.98M1.01-0.7618.56%-50.61%-25.05%1.51

Profit & Loss

Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+0000001.46M5.88M20.65M
Revenue Growth %-------3.03%2.51%
Cost of Goods Sold+078919.46K37.7K37.43K18.79K968.72K5.17M12.2M
COGS % of Revenue------0.66%0.88%0.59%
Gross Profit+0-789-19.46K-37.7K-37.43K-18.79K489.59K713.45K8.45M
Gross Margin %------0.34%0.12%0.41%
Gross Profit Growth %---23.67%-0.94%0.01%0.5%27.06%0.46%10.85%
Operating Expenses+462.49K1.01M940.92K3.28M1.07M1.39M6.17M21.38M27.43M
OpEx % of Revenue------4.23%3.64%1.33%
Selling, General & Admin324.12K938.85K913.79K3.22M1.06M1.39M6.09M20.81M24.5M
SG&A % of Revenue------4.17%3.54%1.19%
Research & Development138.38K71.17K27.13K60.87K3K1K83.28K576.17K2.49M
R&D % of Revenue------0.06%0.1%0.12%
Other Operating Expenses00000000436K
Operating Income+-462.49K-1.01M-960.38K-3.32M-1.1M-1.41M-5.68M-20.67M-18.98M
Operating Margin %-------3.89%-3.52%-0.92%
Operating Income Growth %--1.19%0.05%-2.46%0.67%-0.28%-3.04%-2.64%0.08%
EBITDA+-462.46K-1.01M-940.92K-3.28M-1.07M-1.39M-5.55M-20.51M-18.54M
EBITDA Margin %-------3.81%-3.49%-0.9%
EBITDA Growth %--1.18%0.07%-2.49%0.68%-0.3%-3%-2.69%0.1%
D&A (Non-Cash Add-back)078919.46K37.7K37.43K18.79K128.9K162.62K436K
EBIT-462.46K-1.01M-960.32K-3.37M-1.12M-1.48M-5.44M-20.42M-18.18M
Net Interest Income+-22.49K-26.92K00-1.05K11877.73K-393.6K-175.24K
Interest Income31845806118239.73K129.76K798K
Interest Expense22.52K27K001.06K0162K523.36K973.24K
Other Income/Expense-22.49K-26.91K58-63.29K-21.75K-77.27K77.73K-273.6K-175.24K
Pretax Income+-484.98K-1.04M-960.32K-3.39M-1.12M-1.48M-5.6M-20.94M-19.15M
Pretax Margin %-------3.84%-3.56%-0.93%
Income Tax+02-3000000
Effective Tax Rate %1%1%1%1%1%1%1%1%1%
Net Income+-484.98K-1.04M-960.32K-3.39M-1.12M-1.48M-5.6M-20.94M-19.15M
Net Margin %-------3.84%-3.56%-0.93%
Net Income Growth %--1.14%0.07%-2.53%0.67%-0.32%-2.77%-2.74%0.09%
Net Income (Continuing)-484.98K-1.04M-960.32K-3.39M-1.12M-1.48M-5.6M-20.94M-19.15M
Discontinued Operations000000000
Minority Interest000000000
EPS (Diluted)+-0.25-0.53-0.46-1.57-0.48-0.52-1.41-0.16-0.10
EPS Growth %--1.12%0.13%-2.41%0.69%-0.08%-1.71%0.89%0.38%
EPS (Basic)-0.25-0.53-0.46-1.57-0.48-0.52-1.41-0.16-0.11
Diluted Shares Outstanding1.92M1.95M2.09M2.15M2.34M2.85M3.98M128.45M181.89M
Basic Shares Outstanding1.92M1.95M2.09M2.15M2.34M2.85M3.98M128.45M170.78M
Dividend Payout Ratio---------

Balance Sheet

Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+248.68K463.03K41.55K34.76K163K408.06K4.1M18.38M27.42M
Cash & Short-Term Investments248.22K452.57K35.72K28.47K160.71K405.77K217.18K7.03M466.5K
Cash Only248.22K452.57K35.72K28.47K160.71K405.77K217.18K7.03M466.5K
Short-Term Investments000000000
Accounts Receivable0000002.49M1.65M7.16M
Days Sales Outstanding------623.85102.26126.52
Inventory000000904.1K6.33M10.21M
Days Inventory Outstanding------340.65447.02305.44
Other Current Assets0006.29K0057.45K3.38M5.84M
Total Non-Current Assets+43.55K46.93K103.89K97.76K154.87K20.54K2.89M7.1M14.97M
Property, Plant & Equipment03.38K35.34K84.64K38.21K20.54K1.92M2.99M8.01M
Fixed Asset Turnover------0.76x1.97x2.58x
Goodwill000000000
Intangible Assets00013.12K1.12K036.12K36.12K0
Long-Term Investments0000115.54K002.64M3.62M
Other Non-Current Assets043.55K68.55K000934.05K1.43M3.34M
Total Assets+292.23K509.96K145.43K132.52K317.87K428.61K6.98M25.48M42.39M
Asset Turnover------0.21x0.23x0.49x
Asset Growth %-0.75%-0.71%-0.09%1.4%0.35%15.29%2.65%0.66%
Total Current Liabilities+647.29K408.87K449.78K1.2M1.19M287.28K7.77M9.27M21.33M
Accounts Payable54.83K6.07K10.02K141.42K131.72K124.58K165.48K900.9K2.89M
Days Payables Outstanding-2.81K187.911.37K1.28K2.42K62.3563.6586.39
Short-Term Debt480K030K457.5K195K145K6.24M6.02M15.44M
Deferred Revenue (Current)0000001.78K01000K
Other Current Liabilities44.97K320.3K259.76K104.04K188.7K0020.48K0
Current Ratio0.38x1.13x0.09x0.03x0.14x1.42x0.53x1.98x1.29x
Quick Ratio0.38x1.13x0.09x0.03x0.14x1.42x0.41x1.30x0.81x
Cash Conversion Cycle------902.15485.63345.57
Total Non-Current Liabilities+0000001.89M1.91M7.6M
Long-Term Debt000000469.02K00
Capital Lease Obligations0000001.37M1.91M2.35M
Deferred Tax Liabilities000000000
Other Non-Current Liabilities00000010.63K074.82K
Total Liabilities647.29K408.87K449.78K1.2M1.19M287.28K9.66M11.18M28.93M
Total Debt+480K015K457.5K195K145K8.27M8.22M18.2M
Net Debt231.78K-452.57K-20.72K429.03K34.29K-260.77K8.05M1.19M17.74M
Debt / Equity-----1.03x-0.57x1.35x
Debt / EBITDA---------
Net Debt / EBITDA---------
Interest Coverage-20.54x-37.44x---1041.48x--35.06x-39.49x-19.50x
Total Equity+-355.06K101.09K-304.35K-1.06M-869.05K141.33K-2.68M14.3M13.46M
Equity Growth %-1.28%-4.01%-2.49%0.18%1.16%-19.95%6.34%-0.06%
Book Value per Share-0.190.05-0.15-0.49-0.370.05-0.670.110.07
Total Shareholders' Equity-355.06K101.09K-304.35K-1.06M-869.05K141.33K-2.68M14.3M13.46M
Common Stock1.9K2.06K2.1K2.19K103.5K462.3K12.82K67.07K17.16K
Retained Earnings-485.05K-1.52M-2.48M-5.87M-6.99M-8.48M-3.63M-35.33M-43.66M
Treasury Stock00000-26K000
Accumulated OCI000254.56K00954.52K704.42K150.29K
Minority Interest000000000

Cash Flow

Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+-190.23K-446.86K-443.29K-424.11K-90.54K-363.03K-5.99M-15.36M-9.5M
Operating CF Margin %-------4.11%-2.61%-0.46%
Operating CF Growth %--1.35%0.01%0.04%0.79%-3.01%-15.51%-1.56%0.38%
Net Income-484.98K-1.04M-960.32K-3.39M-1.12M-1.48M-3.21M-20.88M-19.15M
Depreciation & Amortization078919.46K37.7K37.43K18.79K96.58K152.74K436K
Stock-Based Compensation0001.07M434.18K767.24K09.72M14.34M
Deferred Taxes000000000
Other Non-Cash Items-17.33K218.06K-283.32K1.48M20.7K1.18M285.86K5.3M950.61K
Working Capital Changes166.66K324.18K310.5K374.35K541.83K-849.64K-3.16M-9.66M-6.08M
Change in Receivables000000-1.04M-3.07M-4.89M
Change in Inventory000000-780.68K-6.11M-7.69M
Change in Payables145.41K49.42K509.31K000128.84K736.08K1.41M
Cash from Investing+-43.55K-4.17K-23.57K-50.12K-44K38.15K240.82K-453.33K-661.48K
Capital Expenditures-43.55K-4.17K-23.57K-50K-4K00-453.33K-661.48K
CapEx % of Revenue------3.13%0.08%0.03%
Acquisitions---------
Investments---------
Other Investing000-12200000
Cash from Financing+481.9K655.38K50K466.99K266.77K569.95K5.9M22.8M9.43M
Debt Issued (Net)---------
Equity Issued (Net)---------
Dividends Paid000000000
Share Repurchases---------
Other Financing00039.48K2.1K12.9K050K0
Net Change in Cash---------
Free Cash Flow+-233.78K-451.03K-466.86K-474.23K-94.54K-363.03K-1.44M-15.81M-10.16M
FCF Margin %-------0.98%-2.69%-0.49%
FCF Growth %--0.93%-0.04%-0.02%0.8%-2.84%-2.96%-10.01%0.36%
FCF per Share-0.12-0.23-0.22-0.22-0.04-0.13-0.36-0.12-0.06
FCF Conversion (FCF/Net Income)0.39x0.43x0.46x0.13x0.08x0.24x1.07x0.73x0.50x
Interest Paid0003.53K1.06K0000
Taxes Paid000000000

Key Ratios

Metric201620172018201920202021202220232024
Return on Equity (ROE)--1026.5%----1050.28%--360.46%-138%
Return on Invested Capital (ROIC)-------162.24%-148.67%-60.98%
Gross Margin------33.57%12.13%40.93%
Net Margin-------384.11%-356.17%-92.74%
Debt / Equity-----1.03x-0.57x1.35x
Interest Coverage-20.54x-37.44x---1041.48x--35.06x-39.49x-19.50x
FCF Conversion0.39x0.43x0.46x0.13x0.08x0.24x1.07x0.73x0.50x
Revenue Growth-------303.19%251.2%

Revenue by Segment

2024
System Sales Member19.46M
System Sales Member Growth-

Revenue by Geography

2024
INDIA19.08M
INDIA Growth-
INDONESIA595.9K
INDONESIA Growth-
NEPAL501.72K
NEPAL Growth-
South America468.2K
South America Growth-

Frequently Asked Questions

Growth & Financials

SS Innovations International, Inc. (SSII) reported $33.6M in revenue for fiscal year 2024.

SS Innovations International, Inc. (SSII) grew revenue by 251.2% over the past year. This is strong growth.

SS Innovations International, Inc. (SSII) reported a net loss of $17.1M for fiscal year 2024.

Dividend & Returns

SS Innovations International, Inc. (SSII) has a return on equity (ROE) of -138.0%. Negative ROE indicates the company is unprofitable.

SS Innovations International, Inc. (SSII) had negative free cash flow of $22.4M in fiscal year 2024, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.